Clinical trials
Myocardial Infarction clinical trials
Below are recruiting myocardial infarction clinical trials, each written for real people, not researchers. We’re tracking 320 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06955936Recruiting
Blood filtering for shock after heart attack
This trial tests a new blood-filtering device called Efferon CT for people with cardiogenic shock after a heart attack. The device aims to help your body recover by cleaning harmful substances from your blood, and you might join if you are diagnosed early and don't have other serious health issues.
TomskAges 18–80 - NCT07008391Recruiting
High-sensitivity troponin test in ambulance care
This trial tests whether using a high-sensitivity troponin I test in the ambulance, along with standard care, can help emergency medical services better identify heart attacks. This might lead to faster treatment for patients with chest pain or suspected heart attack.
Stockholm, ÅrstaAges 18 years+ - NCT07027891Recruiting
AI ECG test to rule out heart attack in chest pain patients
This study tests if an AI tool reading your ECG can quickly rule out a heart attack in people with chest pain. If you're having chest pain that might be a heart attack, but it's not a severe STEMI type, you may be able to join.
SeoulAges 18 years+ - NCT07077057Recruiting
AI tool for heart attack detection
This trial tests an artificial intelligence system that helps doctors quickly identify heart attacks (myocardial infarction) in patients with symptoms like chest pain or shortness of breath. It aims to speed up diagnosis and treatment.
Lugano, Canton TicinoAges 18 years+ - NCT00794001Recruiting
Timing feedback to improve treatment for heart attack patients
This trial studies whether feedback about treatment timing can help people who are having a specific type of heart attack get treated faster and more effectively. You may be eligible if you arrived for emergency heart catheter treatment soon after symptoms began.
Hildesheim, Lower SaxonyAges Any age - NCT07436429Recruiting
Drug-coated balloon for heart attack treatment
This trial tests if a special balloon that releases medication can be used instead of a stent during emergency angioplasty for certain heart attacks. It may help patients who are having a first-time heart attack and are stable enough for the procedure.
ViennaAges 18 years+ - NCT07469943Recruiting
Diabetes drug after heart attack
This study tests whether a diabetes medication can improve artery health and heart function after a heart attack. It is for people who have had a STEMI and also have diabetes or a weakened heart pump.
Athens, Rimini1/HaidariAges 18–80 - NCT04617639Enrolling by invitation
Exercise program after a heart attack in Norway
This trial tests whether a structured physical exercise plan can help people recover and stay healthier after a heart attack. It is designed for people who can safely be active and are not already doing as much exercise as the program requires.
TrondheimAges 18–79 - NCT04957719Enrolling by invitationPhase 3
Testing selatogrel to prevent problems after a recent heart attack
This trial tests selatogrel to see if it can better prevent harmful heart and blood-clot outcomes after a recent heart attack. You may be considered if you had a heart attack in the past 4 weeks and have higher-risk heart artery disease.
Alexander City, AlabamaAges 18 years+ - NCT07684924Recruiting
Early FAPI PET/MRI after a heart attack
This study uses a new type of PET/MR scan (FAPI) to look at inflammation in the heart shortly after a heart attack. It may help doctors understand recovery better and guide future treatments.
AnkaraAges 18–90 - NCT07181356Recruiting
Remote Ischemic Preconditioning for Heart Attack Recovery
This study tests whether a simple, noninvasive procedure called Remote Ischemic Preconditioning (RIPC) — where a blood pressure cuff is briefly tightened on an arm or leg — can improve long-term recovery for people who have had a heart attack. The treatment is done many times over a long period to see if it helps the heart heal and reduces future problems.
Zhengzhou, HenanAges 18 years+ - NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Shanghai, Shanghai MunicipalityAges 18–100 - NCT06364150RecruitingPhase 3
Stem cell treatment for recent heart attack
This trial tests whether giving specially prepared stem cells from your own blood can help your heart recover after a heart attack. You must have had a successful angioplasty or stenting within the last 4 weeks.
SeoulAges 19–80 - NCT07537868RecruitingPhase 2
Montelukast to reduce heart damage after heart attack
This study tests whether montelukast (a medication that reduces inflammation) can limit heart damage when given immediately after a sudden heart attack. Researchers will measure inflammation markers and heart injury to see if this drug helps patients recover better.
Al MansurahAges 30–75 - NCT03412435Recruiting
Heart attack registry study for patients diagnosed by angiography
This study is a registry, meaning it collects health information from people who are diagnosed with a heart attack. It may help doctors better understand heart attacks and improve care for future patients.
SeoulAges 19 years+ - NCT05689385Recruiting
Online cardiac rehab after a heart attack you can do at home
This trial tests an eHealth (phone or internet-based) cardiac rehabilitation program for people after a heart attack, meant to help you recover with safer activity guidance. It may fit you if you’re not able to go to a rehab clinic in person.
TaipeiAges 20 years+ - NCT06489080Recruiting
Heart attack follow-up study on survival and health
This study looks at how people with heart attacks do over time, including their survival and any heart-related events. It helps doctors understand more about the condition and how to improve care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06562582RecruitingPhase 4
Starting heart drugs after a STEMI heart attack
This study tests whether starting a beta blocker and an SGLT2 inhibitor right after a heart attack can help preserve heart function. It is for STEMI patients who have not yet been treated with these medicines.
GothenburgAges 18 years+ - NCT06689566Recruiting
Genistein for heart attack recovery and inflammation
This study tests whether genistein, a natural compound found in soy, can help reduce inflammation and improve heart health in people who have had a heart attack and are overweight or have other risk factors.
Taipei, TaiwanAges 18 years+ - NCT06738498Recruiting
Delays and heart attack outcomes study
This study looks at how time delays before and during hospital care affect recovery after a heart attack. It may help identify ways to get faster treatment and improve survival.
BaghdadAges 18 years+ - NCT06742567RecruitingPhase 3
Apixaban to prevent blood clots after a heart attack
This trial tests whether the blood thinner apixaban can prevent dangerous blood clots from forming in the heart's main pumping chamber after a specific type of heart attack. It is for patients who have severe weakness of the left ventricle and no clot already present.
Karachi, SindhAges 18–75 - NCT07139860Recruiting
AI system for early warning after a heart attack
This study tests an artificial intelligence system that watches for early signs of complications after a heart attack. If you join, the system may help doctors catch problems sooner.
BeijingAges 18 years+ - NCT07467213RecruitingPhase 3
Acid reflux drug for heart attack recovery
This trial tests if a newer acid-reducing drug is better than standard care for preventing stomach problems in people who recently had a heart attack and a stent placed. It could help those who need stomach protection while on blood thinners.
SeoulAges 19 years+ - NCT06857838Recruiting
Bypass surgery for symptomatic myocardial bridge
This trial tests whether bypass surgery is effective for people with a myocardial bridge (a heart muscle that arches over an artery) that still causes symptoms despite medication. It aims to see if surgery can improve symptoms and outcomes.
Xi'an, ShaanxiAges 18–80
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for myocardial infarction?
- Yes. Clin2 currently lists 320 recruiting myocardial infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a myocardial infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a myocardial infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- STEMI - ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
- ST-segment Elevation Myocardial Infarction (STEMI)
- Cardiogenic Shock Post Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- Acute Myocardial Infarction With ST Elevation
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.